Runben Biotechnology Co., Ltd. (603193)
Market Closed
16 Oct, 06:57 AM
SSE SSE Primary ¥
20. 21
+1.58
+8.4809%
¥
9B Market Cap
- P/E Ratio
0.68% Div Yield
10.5M Volume
- Eps
¥ 18.63
Previous Close Want to track 603193 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Runben Biotechnology Co., Ltd. (603193) Statistics
Valuation metrics
Market Cap 9B
Enterprise value 7.9B
Trailing P/E (ttm) 22.66
Forward P/E -
PEG ratio 1.44
Price/Sales (ttm) 4.74
Price/Book (mrq) 3.45
Enterprise Value/Revenue 4.64
Enterprise Value/EBITDA 19.89
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.21M
Average volume (90 days) 3.16M
Price summary
52-Week low 17.77
52-Week high 28.23
Beta -
50-Day moving average 20.47
200-Day moving average 21.69
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.54
Trailing annual dividend yield 0.0271%
5-Year annual dividend yield -
Payout ratio 0.29
Dividend Date 21 Sep 2026
Ex-Dividend Date 21 Sep 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.21%
Operating margin 0.23%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.16%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.21
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.73
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 8.74%
Book value per share (mrq) 5.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
